Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03628976 · ClinicalTrials.gov registry record · NA

Noninvasive Vagus Nerve Stimulation (VNS) for Neuromotor Adaptations

A NA study of Healthy Young Adults, sponsored by Georgia Institute of Technology.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03628976 is a NA study of Healthy Young Adults that has completed, run by Georgia Institute of Technology. The registered enrollment target is 24 participants, below the 67-participant average among 4 other Healthy Young Adults trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03628976, a NA study of Healthy Young Adults, has completed, sponsored by Georgia Institute of Technology.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The study will examine how electrical stimulation of vagus nerve (i.e. nerve around the outer ear) from the skin surface during motor training influences a brain hormone (called norepinephrine), brain activity, and motor performance.

Conditions Studied

Interventions

  • OTHER tVNS
  • OTHER Motor training

Study Locations (1)

Georgia

  • Human Neuromuscular Physiology Lab - Atlanta

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-05-20
Est. Completion 2021-06-28
Phase NA

Sponsor

Georgia Institute of Technology

24 total trials

What the Registry Record Tells You About NCT03628976

The ClinicalTrials.gov registry entry for NCT03628976 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 67-participant average among 4 other Healthy Young Adults trials with a reported enrollment target (64% lower). The listed sponsor is Georgia Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Young Adults appearing as the primary indexed condition, and to 2 interventions - of which tVNS is the first listed.

NCT03628976 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT03628976 about?

NCT03628976 is a clinical study titled "Noninvasive Vagus Nerve Stimulation (VNS) for Neuromotor Adaptations". The study will examine how electrical stimulation of vagus nerve (i.e. nerve around the outer ear) from the skin surface during motor training influences a brain hormone (called norepinephrine), brain activity, and motor performance.

What is the current status of trial NCT03628976?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-05-20. Estimated completion is 2021-06-28.

What conditions does trial NCT03628976 study?

This clinical trial studies the following conditions: Healthy Young Adults.

What interventions are being tested in trial NCT03628976?

The interventions under investigation include: tVNS (OTHER), Motor training (OTHER).

Who is sponsoring clinical trial NCT03628976?

This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03628976 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Young Adults

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.